ENYO PHARMA
ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public). The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and the BSL4 laboratory Inserm-Jean Mérieux. ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and devel... oped a unique platform for the identification of intracellular therapeutic targets and molecules. The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
ENYO PHARMA
Industry:
Biopharma Biotechnology Medical
Founded:
2014-01-01
Address:
Lyon, Rhone-Alpes, France
Country:
France
Website Url:
http://www.enyopharma.com
Total Employee:
11+
Status:
Active
Contact:
33437700219
Email Addresses:
[email protected]
Total Funding:
64.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Investors List
InnoBio
InnoBio investment in Series B - ENYO Pharma
Bpifrance
Bpifrance investment in Series B - ENYO Pharma
Morningside Venture Investments
Morningside Venture Investments investment in Series B - ENYO Pharma
OrbiMed
OrbiMed investment in Series B - ENYO Pharma
Sofinnova Investments
Sofinnova Investments investment in Series B - ENYO Pharma
Inserm Transfert Initiative
Inserm Transfert Initiative investment in Series B - ENYO Pharma
Andera Partners
Andera Partners investment in Series B - ENYO Pharma
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - ENYO Pharma
Sofinnova Partners
Sofinnova Partners investment in Series A - ENYO Pharma
Official Site Inspections
http://www.enyopharma.com Semrush global rank: 8.82 M Semrush visits lastest month: 249
- Host name: 98-116-176-185.rev.solware.fr
- IP address: 185.116.176.98
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "ENYO Pharma"
About us – ENYO Pharma
About us Company overview Management Board Investors Science Vonafexor series Pipeline Clinical studies Publications Other programs Patients Alport syndrome Ongoing ...See details»
ENYO Pharma – Developing therapeutics for diseases …
Developing therapeutics for diseases with impaired kidney function ENYO Pharma is a clinical-stage biopharmaceutical company. Our mission is to develop highly differentiated therapeutics for improving the quality of life of patients …See details»
Company overview – ENYO Pharma
Company overview Our mission ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The …See details»
ENYO Pharma - LinkedIn
ENYO Pharma | 7,887 followers on LinkedIn. Developing therapeutics for diseases with impaired kidney function | ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti ...See details»
ENYO Pharma - Crunchbase Company Profile & Funding
ENYO Pharma may be growing as it has successfully secured a significant amount of Series C funding, specifically €39 million, which is indicative of investor confidence and financial …See details»
ENYO Pharma Management Team | Org Chart - RocketReach
CHIEF MEDICAL OFFICER at ENYO Pharma Fiesch, Valais, Switzerland View 2 debio.com enyopharma.com 1 4121311XXXXSee details»
ENYO Pharma Company Profile | Management and Employees List …
ENYO Pharma is a privately held, clinical stage biopharmaceutical company incorporated in January 2014 and headquartered in Lyon, France. The Company's most advanced compound, …See details»
Management – ENYO Pharma
Management ENYO Pharma’s team is world class with a crucial mix of pharma senior leadership who proved their scientific excellence and financiers with deep understanding of pharma business. Dr Jacky Vonderscher, PhD, co-founder …See details»
ENYO Pharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for ENYO Pharma. Use the PitchBook Platform to explore the full profile.See details»
ENYO Pharma - Craft
ENYO Pharma has 5 employees at their 1 location and $78 m in total funding,. See insights on ENYO Pharma including office locations, competitors, revenue, financials, executives, …See details»
ENYO Pharma SA - Drug pipelines, Patents, Clinical trials - Synapse
Explore ENYO Pharma SA with its drug pipeline, therapeutic area, technology platform, 15 clinical trials, 8 news, and 5 literature, Disease Domain:Infectious Diseases, Technology …See details»
ENYO Pharma — Sofinnova Partners
Feb 2, 2016 ENYO Pharma is a biotech company specialized in the treatment of acute and chronic viral infections such as hepatitis B. The company is conducting three Phase 2 with its …See details»
Enyo Pharma - VentureRadar
"Biomimetism to discover and develop new drugs. ENYO Pharma is a clinical stage Biotech with a unique drug discovery engine inspired by viruses. The company is currently entering Phase 2 …See details»
ENYO Pharma Company Overview, Contact Details & Competitors …
Apr 6, 2018 Learn more about ENYO Pharma's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
ENYO Pharma
J.P. Morgan week and WuXi Global Forum 2025 in San Francisco 13-16 January, 2025 San Francisco, CA, USA ENYO Pharma will in San Francisco for the J.P Morgan week to …See details»
Enyo Pharma (France) Funding: €103.5M - medicalstartups.org
Apr 2, 2025 ENYO Pharma is a clinical stage Biotech with a unique drug discovery engine inspired by viruses. In particular it develops drug for Chronic Hepatitis...See details»
Cardiovascular, Renal and Metabolism - Morningside
The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.See details»
ENYO PHARMA (LYON) Chiffre d'affaires, résultat, bilans sur …
ENYO PHARMA, société anonyme à conseil d'administration, immatriculée sous le SIREN 799831011, est en activité depuis 10 ans. Localisée à LYON (69008), elle est spécialisée …See details»
ENYO Pharma – Developing therapeutics for diseases with …
Développer des thérapies pour les maladies rénales chroniques ENYO Pharma est une société biopharmaceutique au stade clinique. Notre mission est de développer des molécules aux …See details»
Présentation – ENYO Pharma
Présentation Notre mission ENYO Pharma développe des thérapies innovantes basées sur des propriétés fibrolytiques et anti-inflammatoires pour les maladies liées à l’insuffisance rénale. …See details»